Latest News

Thera4Care partners, University Hospital Essen (UK-Essen) and GE HealthCare have reached an important milestone with the installation of the GE HealthCare StarGuide SPECT/CT system, a state-of-the-art imaging platform designed to advance molecular imaging and support the future of personalised cancer care. Installed in the hospital’s newly inaugurated Nuclear Medicine Center, the StarGuide system will enhance both clinical practice and research and represents an important mil

The 22nd European Symposium on Radiopharmacy and Radiochemistry (ESRR) took place on April 16-19 in Bergen, Norway. Thera4Care was represented by Maria Rosaria Ruggiero from Gemelli Medipass Ergea with a poster titled "Public survey on radiotheranostic landscape by Thera4Care IHI project". More information about the conference can be found here. The next version will be taking place on April 20-23, 2028 in Dijon, France.

Thera4Care's Annual Meeting 2026 took place in Brussels, Belgium, from 5 to 6 May 2026 and hosted by Institut Jules Bordet. Around 60 participants representing consortium partners met together in Brussels to discuss progress of the last 2 years and align on plans for the next year. The first day started with updates from work packages 1 (Project management), 2 (Regulatory) and 9 (Education, Training, Guidelines and Dissemination). The afternoon dove into breakout sessions, wh

The European Molecular Imaging Meeting (EMIM) took place in Ljubljana, Slovenia, from 24 to 27 March 2026. Members from UK-Essen attended the event and presented results from Thera4Care in their two posters titled: Investigating the Effects of Tumor Microenvironment-Targeted Radioligand Therapy on Cancer-Associated Fibroblasts LRRC15-Targeted Radioligand Therapy for the TME-targeted Treatment of Pancreatic Ductal Adenocarcinoma More information about the conference can be fou

The 12th International Conference on Isotopes (12ICI) took place in Florence, Italy, from 15 to 19 February 2026, bringing together scientists, professionals, and stakeholders to share knowledge on the production, applications, and regulation of isotopes across scientific, medical, industrial, and environmental fields. Themes addressed in the conference included: 1) Isotope production and separation; 2) Radiopharmaceuticals and nuclear medicine; 3) Environmental and geologica

The Theranostics World Congress (TWC2026) took place from 29 January to 2 February 2026 in Cape Town, South Africa, where many Thera4Care members were present and actively contributed to the programme. The conference aimed to unite experts from radiochemistry, radiopharmacy, nuclear medicine, oncology, emerging fields, and beyond — fostering scientific excellence and accelerating the translation of research into clinical practice in oncology. The main topics of the congress w

The molecular blueprint of targeted radionuclide therapy A major review just published by members of Thera4Care in Nature Reviews Clinical Oncology outlines how a promising approach in oncology known as targeted radionuclide therapy (TRT) is rapidly evolving through a deeper understanding of molecular targets and their central role in achieving precise, personalised treatment across a wide range of cancers. The paper is authored by Irina Primac, Kevin Tabury and Sarah Baato

Thera4Care was featured at the EANM25 Congress , which took place on 4 – 8 October 2025 in Barcelona, organised by the project partner...

On 28 April 2025, Università Cattolica del Sacro Cuore and Fondazione Policlinico Universitario Agostino Gemelli—coordinators of the...